Treatment of Inherited Factor VII Deficiency

计划入组 223 人 · 首次发布于 2011 年 1 月 4 日

Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency

计划入组 24 人 · 首次发布于 2017 年 3 月 14 日

A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency

计划入组 12 人 · 首次发布于 2026 年 7 月 17 日

Coagulation factor VII human(Balfaxar, Beriplex, Kcentra, Octaplex)

recombinant coagulation factor VII

Stabile-7

MAGNESIUM FACTOR PTY LTD

Australia

King Edward VII Memorial Hospital

Bermuda

MOTHER SUN PROTECTION FACTOR PTY LTD

Australia

Hemab Therapeutics Files for NASDAQ IPO to Advance Bleeding Disorder Therapies

Hemab Therapeutics Advances Bleeding Disorder Pipeline with Promising Clinical Data at ISTH 2025

Hemab Therapeutics Unveils HMB-002 Proof-of-Mechanism Data in VWD and Announces Novel Antifibrinolytic HMB-003 at ISTH 2026